Body weight and cancer screening among women

K. R. Fontaine, Moonseong Heo, D. B. Allison

Research output: Contribution to journalArticle

89 Citations (Scopus)

Abstract

Obesity increases cancer risk, yet small-scale surveys indicate that obese women delay or avoid cancer screening even more so than do nonobese women. We sought to estimate the association between body mass index (BMI) (kg/m2) and delayed cancer screening among adult women in a population-based survey. Subjects were women classified by BMI as underweight (<18.5), desirable weight (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III (≥40). Outcome measures were intervals (0 for ≤2 years versus 1 for >2 years) since most recent screening for Papanicolaou (Pap) smear, mammography, and clinical breast examination (CBE). Adjusting for age, race, smoking, and health insurance, we observed J-shaped associations between BMI and screening. Compared with desirable weight women, underweight women (odds ratios [OR] = 1.21, 95% confidence interval [95% CI] 1.09-1.34), overweight women (OR = 1.13, 95% CI 1.07-1.18), and obese women (OR range 1.22-1.69) were significantly more likely to delay Pap smear testing for >2 years. Underweight (OR = 1.32, 95% CI 1.13-1.54), obesity class I (OR = 1.12, 95% CI 1.02-1.23), and obesity class III women (OR = 1.32, 95% CI 1.10-1.54) were more likely to delay mammography, and overweight (OR = 1.10, 95% CI 1.01-1.19), obesity class I (OR = 1.18, 95% CI 1.08-1.30), and obesity class III women (OR = 1.47, 95% CI 1.23-1.75) were more likely to delay CBE. White women were more likely to delay CBE as a function of BMI than were non-white women. Weight may be an important correlate of cancer screening behavior, particularly for white women.

Original languageEnglish (US)
Pages (from-to)463-470
Number of pages8
JournalJournal of Women's Health and Gender-Based Medicine
Volume10
Issue number5
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Early Detection of Cancer
Body Weight
Odds Ratio
Confidence Intervals
Obesity
Thinness
Body Mass Index
Papanicolaou Test
Breast
Mammography
Weights and Measures
Mass Screening
Health Insurance
Smoking

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Body weight and cancer screening among women. / Fontaine, K. R.; Heo, Moonseong; Allison, D. B.

In: Journal of Women's Health and Gender-Based Medicine, Vol. 10, No. 5, 2001, p. 463-470.

Research output: Contribution to journalArticle

Fontaine, K. R. ; Heo, Moonseong ; Allison, D. B. / Body weight and cancer screening among women. In: Journal of Women's Health and Gender-Based Medicine. 2001 ; Vol. 10, No. 5. pp. 463-470.
@article{5c23eefc1a03435299ecead8c566c672,
title = "Body weight and cancer screening among women",
abstract = "Obesity increases cancer risk, yet small-scale surveys indicate that obese women delay or avoid cancer screening even more so than do nonobese women. We sought to estimate the association between body mass index (BMI) (kg/m2) and delayed cancer screening among adult women in a population-based survey. Subjects were women classified by BMI as underweight (<18.5), desirable weight (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III (≥40). Outcome measures were intervals (0 for ≤2 years versus 1 for >2 years) since most recent screening for Papanicolaou (Pap) smear, mammography, and clinical breast examination (CBE). Adjusting for age, race, smoking, and health insurance, we observed J-shaped associations between BMI and screening. Compared with desirable weight women, underweight women (odds ratios [OR] = 1.21, 95{\%} confidence interval [95{\%} CI] 1.09-1.34), overweight women (OR = 1.13, 95{\%} CI 1.07-1.18), and obese women (OR range 1.22-1.69) were significantly more likely to delay Pap smear testing for >2 years. Underweight (OR = 1.32, 95{\%} CI 1.13-1.54), obesity class I (OR = 1.12, 95{\%} CI 1.02-1.23), and obesity class III women (OR = 1.32, 95{\%} CI 1.10-1.54) were more likely to delay mammography, and overweight (OR = 1.10, 95{\%} CI 1.01-1.19), obesity class I (OR = 1.18, 95{\%} CI 1.08-1.30), and obesity class III women (OR = 1.47, 95{\%} CI 1.23-1.75) were more likely to delay CBE. White women were more likely to delay CBE as a function of BMI than were non-white women. Weight may be an important correlate of cancer screening behavior, particularly for white women.",
author = "Fontaine, {K. R.} and Moonseong Heo and Allison, {D. B.}",
year = "2001",
doi = "10.1089/152460901300233939",
language = "English (US)",
volume = "10",
pages = "463--470",
journal = "Journal of Women's Health",
issn = "1540-9996",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Body weight and cancer screening among women

AU - Fontaine, K. R.

AU - Heo, Moonseong

AU - Allison, D. B.

PY - 2001

Y1 - 2001

N2 - Obesity increases cancer risk, yet small-scale surveys indicate that obese women delay or avoid cancer screening even more so than do nonobese women. We sought to estimate the association between body mass index (BMI) (kg/m2) and delayed cancer screening among adult women in a population-based survey. Subjects were women classified by BMI as underweight (<18.5), desirable weight (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III (≥40). Outcome measures were intervals (0 for ≤2 years versus 1 for >2 years) since most recent screening for Papanicolaou (Pap) smear, mammography, and clinical breast examination (CBE). Adjusting for age, race, smoking, and health insurance, we observed J-shaped associations between BMI and screening. Compared with desirable weight women, underweight women (odds ratios [OR] = 1.21, 95% confidence interval [95% CI] 1.09-1.34), overweight women (OR = 1.13, 95% CI 1.07-1.18), and obese women (OR range 1.22-1.69) were significantly more likely to delay Pap smear testing for >2 years. Underweight (OR = 1.32, 95% CI 1.13-1.54), obesity class I (OR = 1.12, 95% CI 1.02-1.23), and obesity class III women (OR = 1.32, 95% CI 1.10-1.54) were more likely to delay mammography, and overweight (OR = 1.10, 95% CI 1.01-1.19), obesity class I (OR = 1.18, 95% CI 1.08-1.30), and obesity class III women (OR = 1.47, 95% CI 1.23-1.75) were more likely to delay CBE. White women were more likely to delay CBE as a function of BMI than were non-white women. Weight may be an important correlate of cancer screening behavior, particularly for white women.

AB - Obesity increases cancer risk, yet small-scale surveys indicate that obese women delay or avoid cancer screening even more so than do nonobese women. We sought to estimate the association between body mass index (BMI) (kg/m2) and delayed cancer screening among adult women in a population-based survey. Subjects were women classified by BMI as underweight (<18.5), desirable weight (18.5-24.9), overweight (25-29.9), obese class I (30-34.9), obese class II (35-39.9), and obese class III (≥40). Outcome measures were intervals (0 for ≤2 years versus 1 for >2 years) since most recent screening for Papanicolaou (Pap) smear, mammography, and clinical breast examination (CBE). Adjusting for age, race, smoking, and health insurance, we observed J-shaped associations between BMI and screening. Compared with desirable weight women, underweight women (odds ratios [OR] = 1.21, 95% confidence interval [95% CI] 1.09-1.34), overweight women (OR = 1.13, 95% CI 1.07-1.18), and obese women (OR range 1.22-1.69) were significantly more likely to delay Pap smear testing for >2 years. Underweight (OR = 1.32, 95% CI 1.13-1.54), obesity class I (OR = 1.12, 95% CI 1.02-1.23), and obesity class III women (OR = 1.32, 95% CI 1.10-1.54) were more likely to delay mammography, and overweight (OR = 1.10, 95% CI 1.01-1.19), obesity class I (OR = 1.18, 95% CI 1.08-1.30), and obesity class III women (OR = 1.47, 95% CI 1.23-1.75) were more likely to delay CBE. White women were more likely to delay CBE as a function of BMI than were non-white women. Weight may be an important correlate of cancer screening behavior, particularly for white women.

UR - http://www.scopus.com/inward/record.url?scp=0034913349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034913349&partnerID=8YFLogxK

U2 - 10.1089/152460901300233939

DO - 10.1089/152460901300233939

M3 - Article

VL - 10

SP - 463

EP - 470

JO - Journal of Women's Health

JF - Journal of Women's Health

SN - 1540-9996

IS - 5

ER -